As the conference approaches, scientists are reviewing new technologies that enhance manufacturing process control, product ...

By combining technical expertise, strategic leadership, and a collaborative approach, Karunakar Grandhe is helping clients in ...

A 100% tariff on imported pharmaceuticals aims to boost US manufacturing, with exemptions for companies building domestic facilities. Major pharmaceutical companies are investing billions in US ...

The current pharmaceutical landscape demands a change in mindset. Success requires balancing speed, cost and quality while ...

Integrated systems allow companies to release products faster, adapt more quickly to regulatory changes and scale globally ...

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced that current board member and former advisory board member Tim M. Mayleben ...

The merger strengthens and expands TAI’s ability to deliver design-build and general contracting services across diverse markets, including industrial, food and beverage, chemical and process, ...

Over the past decade, pharmaceutical maker Pfizer ( PFE -0.53%) has severely lagged the market. Dividends reinvested aside, the stock is in the red over this period, while the S&P 500 is up by almost ...

Jamkas Pharmaceuticals is a cost-effective third-party manufacturing company that offers emerging pharma medicine brands with ...

Eli Lilly’s $1 billion Hyderabad investment promises fresh opportunities in pharma manufacturing and management. Here’s how students and graduates can prepare for roles in one of India’s fastest-growi ...

Not just any pharmaceutical stock will do, though. They aren't all created equal. Let's discuss two leaders in the industry ...

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-dependent ...